In summary, based on the observation that miR-30a is downregulated in podocyte injury models and glomeruli of FSGS patients, the present study demonstrates for the first time that miR-30a inhibits EMT to protect podocyte functions by targeting NFATc3. The gene discussed is NFATC3; the disease is focal segmental glomerulosclerosis.